اخبار و اعلانات

 آمار

تعداد نشریات284
تعداد نشریات سازمان82
تعداد شماره‌ها3,037
تعداد مقالات33,984
تعداد مشاهده مقاله45,772,805
تعداد دریافت فایل اصل مقاله77,191,228
Mahmood Shakir, H. (1400). Safety of Vaginal Misoprostol for the Termination of Second Trimester Miscarriage in Women with Previous Uterine Scar in Iraq. سامانه مدیریت نشریات علمی, 77(1), 199-204. doi: 10.22092/ari.2021.356535.1862
H Mahmood Shakir. "Safety of Vaginal Misoprostol for the Termination of Second Trimester Miscarriage in Women with Previous Uterine Scar in Iraq". سامانه مدیریت نشریات علمی, 77, 1, 1400, 199-204. doi: 10.22092/ari.2021.356535.1862
Mahmood Shakir, H. (1400). 'Safety of Vaginal Misoprostol for the Termination of Second Trimester Miscarriage in Women with Previous Uterine Scar in Iraq', سامانه مدیریت نشریات علمی, 77(1), pp. 199-204. doi: 10.22092/ari.2021.356535.1862
Mahmood Shakir, H. Safety of Vaginal Misoprostol for the Termination of Second Trimester Miscarriage in Women with Previous Uterine Scar in Iraq. سامانه مدیریت نشریات علمی, 1400; 77(1): 199-204. doi: 10.22092/ari.2021.356535.1862

Safety of Vaginal Misoprostol for the Termination of Second Trimester Miscarriage in Women with Previous Uterine Scar in Iraq

Archives of Razi Institute
مقاله 27، دوره 77، شماره 1، فروردین و اردیبهشت 2022، صفحه 199-204    اصل مقاله (447.47 K)
نوع مقاله: Original Articles
شناسه دیجیتال (DOI): 10.22092/ari.2021.356535.1862
نویسنده
H Mahmood Shakir*
Ibn Sina University of Medical and Pharmaceutical Sciences, Baghdad, Iraq
چکیده
Pregnancy termination for a variety of fetal or maternal conditions has been defined as one of the common obstetrical procedures. The presence of an earlier uterine scar has been found as a highly significant risk factor, which needs to be considered before the election of the misoprostol for the termination of pregnancy (TOP) uses. This study aimed to evaluate the safety of vaginal misoprostol in patients who had an earlier uterine scar, and whether its utilization might result in increasing the risks of uterine ruptures. In total, 250 participants were included in the experimental model and divided into two groups including 95 patients in their 2nd  trimester of pregnancy with confirmed non-viable fetus and scarred uterus (study group) and 155 pregnant women with no scar in their uterus and missed miscarriage (control group). They received misoprostol tablets in accordance with the Security Hospital Protocol for the TOP. The safety has been specified according to the number of women that had full abortions with no complications. The study group with uterine scar included 95 cases that comprised 38% of the total participants in the study (n=250). Out of 95 cases, 64 (67.3%) patients had successful abortions completely, compared to the control group (the patients with no scar), 111 (71.6%) of whom had complete abortions (P<0.001). However, 44 (28.4%) and 31 (32.6%) patients in the control and study groups, respectively, were in need of surgical evacuations either for the incomplete conception product expulsion or as a result of the excessive per-vaginal bleeding. The use of the misoprostol for the TOP has not been contra-indicated in the females who had Caesarean scars. Moreover, it is efficient in females who do not have scarred uterus.
کلیدواژه‌ها
Caesarean؛ Pregnant؛ Termination of pregnancy
سایر فایل های مرتبط با مقاله
مراجع
  1. Organization WH. Safe abortion: technical and policy guidance for health systems: World Health Organization; 2012.
  2. Keder LM. Best practices in surgical abortion. Am J Obstet Gynecol. 2003;189(2):418-22.
  3. KIRTON KT. Prostaglandins and reproduction. The Prostaglandins: Progress in Research. 2012:47.
  4. Chamsi A, Morsy E, El Rifaei R, Al Bahyan R. The Safety of Misoprostol for Medical Termination of Pregnancy in First and Second Trimester in Women with Previous Uterine Scar. Insights Reprod Med. 2018;2(1):3.
  5. Goldberg AB, Greenberg MB, Darney PD. Misoprostol and pregnancy. N Engl J Med. 2001;344(1):38-47.
  6. Ashok P, Penney G, Flett G, Templeton A. An effective regimen for early medical abortion: a report of 2000 consecutive cases. Hum Reprod (Oxford, England). 1998;13(10):2962-5.
  7. Mazouni C, Provensal M, Porcu G, Guidicelli B, Heckenroth H, Gamerre M, et al. Termination of pregnancy in patients with previous cesarean section. Contraception. 2006;73(3):244-8.
  8. Sirimai K, Kiriwat O, Neungton S, Suvanichchati S. Misoprostal use for therapeutic abortion in Siriraj Hospital: the year 2000. J Med Assoc Thail=Chotmaihet Thangphaet. 2002;85(4):416-23.
  9. Ngoc NTN, Blum J, Westheimer E, Quan TTV, Winikoff B. Medical treatment of missed abortion using misoprostol. Int J Gynaecol Obstet. 2004;87(2):138-42.
  10. Munthali J, Moodley J. The use of misoprostol for mid-trimester therapeutic termination of pregnancy. Tropical doctor. 2001;31(3):157-61.
  11. Güleç ÜK, Urunsak IF, Eser E, Guzel AB, Ozgunen FT, Evruke IC, et al. Misoprostol for midtrimester termination of pregnancy in women with 1 or more prior cesarean deliveries. Int J Gynaecol Obstet. 2013;120(1):85-7.
  1. Dickinson JE. Misoprostol for second-trimester pregnancy termination in women with a prior cesarean delivery. Obstet Gynecol. 2005;105(2):352-6.
  2. Cuellar Torriente M, Steinberg WJ, Joubert G. Misoprostol use for second‐trimester termination of pregnancy among women with one or more previous cesarean deliveries. Int J Gynaecol Obstet. 2017;138(1):23-7.
  1. Fawzy M, Abdel-Hady E-S. Midtrimester abortion using vaginal misoprostol for women with three or more prior cesarean deliveries. Int J Gynaecol Obstet. 2010;110(1):50-2.
15.          Daponte A, Nzewenga G, Dimopoulos K, Guidozzi F. Pregnancy termination using vaginal misoprostol in women with more than one caesarean section. J Obstet Gynaecol. 2007;27(6):597-600. 

آمار
تعداد مشاهده مقاله: 1,739
تعداد دریافت فایل اصل مقاله: 2,601


counter
سامانه مدیریت نشریات علمی. طراحی و پیاده سازی از سیناوب